Silexion Therapeutics share price logo

Silexion Therapeutics

NASDAQ: SLXN

$0.36

-0.01

(-2.57%)

Live

as on

Silexion Therapeutics Stock Performance

as on September 3, 2026 at 4:06 am IST

  • Day's Low

    Day's High

    $0.35
    $0.39
    downward going graph

    2.78%

    Downside

    8.33%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.35
    $77.70
    downward going graph

    2.75%

    Downside

    21483.33%

    Upside

    downward going graph

Silexion Therapeutics share price movements today

Previous Close
$0.37
Open
$0.38
Volume
251.4K
Market Cap
$2.1M
Day's Low - High
$0.35 - $0.39
52 Week Low - High
$0.35 - $77.70

Silexion Therapeutics Historical Returns

1 Month Return
-80.31 %
3 Month Return
-92.58 %
1 Year Return
-99.49 %
3 Year Return
0 %
5 Year Return
0 %

Silexion Therapeutics Stock Fundamentals & Key Indicators

Check Silexion Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.1M

EPS (TTM)

-56.58

Dividend Yield

0.00%

PE Ratio (TTM)

-0.01

Industry PE ratio

-1.4626335877862595

PEG Ratio

-0.00001585990540775939

Return On Equity TTM

-563.11%

Silexion Therapeutics Stock Valuation

Track how Silexion Therapeutics P/E has moved over time to understand its valuation trends.

Silexion Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-5753.42x)

December 31, 2021

Industry (-1.46x)

December 31, 2025

Today (-0.21x)

December 31, 2025

Highest (-0.21x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.21x

Silexion Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Silexion Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Neutral$2.1MNA-0.010.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$137.9B174.9%31.9286.04%NA
BUY$61.6B-61.21%-7.98-12.57%NA
BUY$82.3B21.91%19.984.86%0.44%

Stock Returns calculator for Silexion Therapeutics Stock including INR - Dollar returns

The Silexion Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Silexion Therapeutics investment value today

Current value as on today

₹539

Returns

-₹99,461

(-99.46%)

Returns from Silexion Therapeutics Stock

-₹99,501 (-99.5%)

Dollar Impact

₹39 (+0.04%)

Analyst Recommendation on Silexion Therapeutics Stock

Based on 1 analysts

HOLD

0.00%

Buy

100.00%

Hold

0.00%

Sell

Indian Investors' Interest in Silexion Therapeutics Stock

Search interest for Silexion Therapeutics Stock has increased by 88% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:88% versus previous 30 day period

Silexion Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
-
-
-
0
-
0
0
Operating Income
-1
-1
-8
-1
-1
-2
-3
18
-2
-3
EBITDA
-1
-1
-11
-5
-1
-2
-3
-4
-2
-3
Interest Expense
-
0
0
-
0
-
-
0
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
-1
-11
-1
-1
-2
-3
-4
-2
-3
Income Tax Expense
0
0
0
0
-
0
-
-
-
-
Net Income
-1
-1
-11
-1
-1
-2
-3
-4
-2
-3
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Silexion Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
Operating Income
0
0
-3
-4
-12
11
EBITDA
0
0
-3
-5
-16
-11
Interest Expense
-
-
0
0
0
0
Depreciation
-
-
0
0
0
0
Income Before Tax
0
0
-3
-5
-16
-11
Income Tax Expense
-
-
0
0
0
0
Net Income
0
0
-3
-4
-16
-11
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Silexion Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-1
-1
-11
-1
-1
-2
-3
-4
-2
-3
Operating Cash Flow
-1
-1
-2
-2
-2
-2
-2
-3
-3
-2
Investing Cash Flow
0
-
0
-
0
0
-
0
-
0
Financing Cash Flow
-
-
2
2
7
0
8
0
0
2
Change in Cash
-1
-1
0
0
4
-2
5
-3
-3
0

Silexion Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
0
-3
-5
-16
-11
Operating Cash Flow
0
-1
-3
-4
-8
-10
Investing Cash Flow
-
-
0
0
0
0
Financing Cash Flow
0
116
2
0
5
15
Change in Cash
0
0
-1
-3
-3
4

Global Institutional Holdings in Silexion Therapeutics

Funds
Holdings
UBS Group AG
0.01%
Pflug Koory, LLC.
0%
JONES FINANCIAL COMPANIES LLLP
0%
Pflug Koory, LLC.
0.01%
SBI Securities Co Ltd
0%

Insights on Silexion Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, SLXN stock has moved up by 4.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 537.7% return, outperforming this stock by 637.2%

About Silexion Therapeutics

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
OrganisationSilexion Therapeutics
HeadquartersThe Goldyne Savad Inst. of Gene Therapy, Jerusalem, Israel, 9112001
IndustryBiotechnology
CEOMr. Ilan Hadar M.B.A.
E-voting on sharesClick here to vote

Key Management of Silexion Therapeutics

Name

Title

Mr. Ilan Hadar M.B.A.

Chairman & CEO

Ms. Mirit Horenshtein Hadar

EVP of Finance Affairs, CFO & Secretary

Dr. Mitchell Shirvan M.B.A., Ph.D.

Chief Scientific & Development Officer

FAQs

What is Silexion Therapeutics share price today?

Silexion Therapeutics share price today is $0.36 as on . Silexion Therapeutics share today touched a day high of $0.39 and a low of $0.35.

What is the 52 week high and 52 week low for Silexion Therapeutics share?

Silexion Therapeutics share touched a 52 week high of $77.70 on and a 52 week low of $0.35 on . Silexion Therapeutics stock price today i.e. is trending at $0.36,which is 99.54% down from its 52 week high and 2.83% up from its 52 week low.

What is Silexion Therapeutics's market capitalisation today?

Silexion Therapeutics market capitalisation is $0.00T as on .

How to invest in Silexion Therapeutics Stock (SLXN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Silexion Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Silexion Therapeutics Shares that will get you 4.1667 shares as per Silexion Therapeutics share price of $0.36 per share as on September 2, 2026 at 10:36 pm IST.

What is the minimum amount required to buy Silexion Therapeutics Stock (SLXN) from India?

Indian investors can start investing in Silexion Therapeutics (SLXN) shares with as little as ₹94.96 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Silexion Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Silexion Therapeutics share’s latest price of $0.36 as on September 2, 2026 at 10:36 pm IST, you will get 27.7778 shares of Silexion Therapeutics. Learn more about fractional shares .